Literature DB >> 10335469

In vitro fertilization outcome according to age and follicle-stimulating hormone levels on cycle day 3.

S Bassil1, P A Godin, S Gillerot, J C Verougstraete, J Donnez.   

Abstract

PURPOSE: In a retrospective study, the prognostic factors of in vitro fertilization outcome were studied in women of 39 years of age or older, with an elevated cycle day 3 follicle-stimulating hormone (FSH) level.
METHODS: Ovarian stimulation was achieved with a combination of gonadotropin-releasing hormone agonist/human menopausal gonadotropin in a short protocol. All patients underwent FSH dosage on cycle day 3 prior to stimulation. The pregnancy rate was studied according to age, FSH levels, and stimulation parameters.
RESULTS: There was a negative correlation between day 3 FSH levels and the number of ovocytes retrieved. Cycles canceled because of the absence of ovarian response had a significantly higher mean FSH value (18.2 mlU/ml) than cycles ending in ovocyte retrieval (14.6 mlU/ml). Patients with three or more growing follicles during stimulation achieved a significantly higher pregnancy rate per egg retrieval (16%) compared to patients with fewer than three growing follicles (6%). Eighty percent of those pregnancies were obtained during the first two IVF cycles. Even with an elevated FSH level, some patients developed three or more follicles after stimulation. In such cases, the number of embryos available for transfer was the only significant limiting factor to achieving pregnancy.
CONCLUSIONS: As our results suggest, there is a discrepancy between biological and chronological ovarian age. In patients with an elevated cycle day 3 FSH level and over 40 years of age, alternatives to fertility treatments (ovum donation, adoption, or no treatment) should not be considered as first choices. Indeed, even with elevated FSH levels, a 16% pregnancy rate per egg retrieval may be obtained if three or more growing follicles can be seen during ovarian stimulation. However, in the presence of fewer than three growing follicles during ovarian stimulation, the patient should be informed about the discouraging prognosis of the running cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335469      PMCID: PMC3455712          DOI: 10.1023/a:1020359211343

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  21 in total

1.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

2.  Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test.

Authors:  E Loumaye; J M Billion; J M Mine; I Psalti; M Pensis; K Thomas
Journal:  Fertil Steril       Date:  1990-02       Impact factor: 7.329

3.  Effect of parental age on fertilization and pregnancy characteristics in couples treated by intracytoplasmic sperm injection.

Authors:  S D Spandorfer; O M Avrech; L T Colombero; G D Palermo; Z Rosenwaks
Journal:  Hum Reprod       Date:  1998-02       Impact factor: 6.918

4.  Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization.

Authors:  R T Scott; G E Hofmann; S Oehninger; S J Muasher
Journal:  Fertil Steril       Date:  1990-08       Impact factor: 7.329

5.  Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization.

Authors:  J M Jenkins; D W Davies; H Devonport; F W Anthony; S C Gadd; R H Watson; G M Masson
Journal:  Hum Reprod       Date:  1991-08       Impact factor: 6.918

6.  Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.

Authors:  G Lavy; A Pellicer; M P Diamond; A H DeCherney
Journal:  Fertil Steril       Date:  1988-07       Impact factor: 7.329

7.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

8.  Fertility prognosis in IVF treatment of patients with cancelled cycles.

Authors:  M Van Rysselberge; F Puissant; P Barlow; B Lejeune; A Delvigne; F Leroy
Journal:  Hum Reprod       Date:  1989-08       Impact factor: 6.918

9.  Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

Authors:  R T Scott; J P Toner; S J Muasher; S Oehninger; S Robinson; Z Rosenwaks
Journal:  Fertil Steril       Date:  1989-04       Impact factor: 7.329

10.  Incidence of early loss of pregnancy.

Authors:  A J Wilcox; C R Weinberg; J F O'Connor; D D Baird; J P Schlatterer; R E Canfield; E G Armstrong; B C Nisula
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

View more
  3 in total

1.  Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders.

Authors:  Pu-Tsui Wang; Robert Kuo-kuang Lee; Jin-Tsung Su; Jen-Wan Hou; Ming-Huei Lin; Yu-Ming Hu
Journal:  J Assist Reprod Genet       Date:  2002-01       Impact factor: 3.412

2.  The dilemma of counseling patients about poor prognosis: live birth after IVF with autologous oocytes in a 43-year-old woman with FSH levels above 30 mIU/mL.

Authors:  Heather R Burks; Marsha Baker; Alexander M Quaas; Kristin A Bendikson; Karine Chung; Richard J Paulson
Journal:  J Assist Reprod Genet       Date:  2017-06-27       Impact factor: 3.412

3.  Roles of kisspeptin in IVF/ICSI-treated infertile women and in human granulosa cells.

Authors:  Lixian Qin; Chantacha Sitticharoon; Somsin Petyim; Issarawan Keadkraichaiwat; Rungnapa Sririwichitchai; Pailin Maikeaw; Malika Churintaraphan; Chanakarn Sripong
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.